Agilent Technologies, Inc. (NYSE:A) remains on the limelight, with various institutional and individual investors adjusting their stakes in the company. Notable transactions include BI Asset Management Fondsmaeglerselskab A S disposing 6,469 shares, J. Safra Sarasin Holding AG buying 9,219 shares, and State of Tennessee Department of Treasury dislodging 3,473 shares. Despite
Agilent beating Q1 earnings and revenue estimates, its stock fell following cautious FY25 view. The company is scheduled to announce its second-quarter fiscal year 2025 results on May 28. Its tools nabbed the spot for
'2025 Coolest Thing Made in Delaware', and it recently acquired lab instrument monitoring firm Sigsense, further elevating its diagnostic capabilities. However, insider trading raised concern as certain stakeholders sold significant Agilent's stock. As operations expand,
Agilent's stock performance is expected to steer the bio-tech market sentiments.
Agilent Technologies A News Analytics from Tue, 30 Jul 2024 07:00:00 GMT to Sat, 26 Apr 2025 23:54:07 GMT -
Rating 4
- Innovation 6
- Information 8
- Rumor 3
